Genesco Financial Statements (GCO)
|
|
Report date
|
|
|
27.05.2021 |
23.03.2022 |
22.03.2023 |
31.01.2024 |
27.03.2024 |
|
12.09.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
1 787 |
2 422 |
2 385 |
2 325 |
2 325 |
|
1 966 |
Operating Income, bln rub |
|
|
42.1 |
104.4 |
51.0 |
16.8 |
-13.5 |
|
-82.9 |
EBITDA, bln rub |
? |
|
-59.7 |
190.4 |
136.7 |
23.6 |
35.8 |
|
-57.4 |
Net profit, bln rub |
? |
|
-56.0 |
114.9 |
71.9 |
-16.8 |
-16.8 |
|
-68.7 |
|
OCF, bln rub |
? |
|
157.7 |
239.9 |
-164.9 |
|
94.8 |
|
-6.03 |
CAPEX, bln rub |
? |
|
24.1 |
53.9 |
59.9 |
|
60.3 |
|
14.3 |
FCF, bln rub |
? |
|
133.6 |
186.0 |
-224.8 |
|
34.5 |
|
-20.3 |
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
|
0.000 |
|
0.000 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
OPEX, bln rub |
|
|
813.8 |
1 034 |
1 042 |
1 082 |
1 082 |
|
1 006 |
Cost of production, bln rub |
|
|
982.1 |
1 241 |
1 249 |
1 226 |
1 226 |
|
1 042 |
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
Interest expenses, bln rub |
|
|
5.09 |
2.45 |
2.92 |
7.78 |
7.78 |
|
4.47 |
|
Assets, bln rub |
|
|
1 587 |
1 562 |
1 456 |
1 330 |
1 330 |
|
1 384 |
Net Assets, bln rub |
? |
|
566.8 |
602.5 |
607.0 |
571.2 |
571.2 |
|
532.6 |
Debt, bln rub |
|
|
734.0 |
632.6 |
580.4 |
522.9 |
522.9 |
|
530.1 |
Cash, bln rub |
|
|
215.1 |
320.5 |
48.0 |
35.2 |
35.2 |
|
45.9 |
Net debt, bln rub |
|
|
518.9 |
312.1 |
532.4 |
487.8 |
487.8 |
|
484.3 |
|
Ordinary share price, rub |
|
|
38.8 |
62.9 |
47.8 |
27.8 |
28.8 |
|
27.0 |
Number of ordinary shares, mln |
|
|
14.2 |
14.2 |
12.5 |
11.2 |
11.2 |
|
10.9 |
|
Market cap, bln rub |
|
|
552 |
892 |
595 |
312 |
324 |
|
295 |
EV, bln rub |
? |
|
1 071 |
1 204 |
1 127 |
800 |
812 |
|
779 |
Book value, bln rub |
|
|
497 |
534 |
541 |
571 |
534 |
|
496 |
|
EPS, rub |
? |
|
-3.94 |
8.11 |
5.77 |
-1.50 |
-1.50 |
|
-6.28 |
FCF/share, rub |
|
|
9.40 |
13.1 |
-18.0 |
0.00 |
3.07 |
|
-1.86 |
BV/share, rub |
|
|
35.0 |
37.7 |
43.5 |
50.8 |
47.5 |
|
45.3 |
|
EBITDA margin, % |
? |
|
-3.34% |
7.86% |
5.73% |
1.01% |
1.54% |
|
-2.92% |
Net margin, % |
? |
|
-3.14% |
4.74% |
3.02% |
-0.72% |
-0.72% |
|
-3.49% |
FCF yield, % |
? |
|
24.2% |
20.9% |
-37.8% |
0.00% |
10.6% |
|
-6.88% |
ROE, % |
? |
|
-9.89% |
19.1% |
11.8% |
-2.95% |
-2.95% |
|
-12.9% |
ROA, % |
? |
|
-3.53% |
7.35% |
4.94% |
-1.27% |
-1.27% |
|
-4.96% |
|
P/E |
? |
|
-9.85 |
7.77 |
8.27 |
-18.6 |
-19.2 |
|
-4.30 |
P/FCF |
|
|
4.13 |
4.80 |
-2.65 |
|
9.39 |
|
-14.5 |
P/S |
? |
|
0.31 |
0.37 |
0.25 |
0.13 |
0.14 |
|
0.15 |
P/BV |
? |
|
1.11 |
1.67 |
1.10 |
0.55 |
0.61 |
|
0.59 |
EV/EBITDA |
? |
|
-17.9 |
6.32 |
8.25 |
33.9 |
22.6 |
|
-13.6 |
Debt/EBITDA |
|
|
-8.70 |
1.64 |
3.90 |
20.7 |
13.6 |
|
-8.44 |
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
|
0.00% |
|
0 |
|
CAPEX/Revenue, % |
|
|
1.35% |
2.23% |
2.51% |
0.00% |
2.59% |
|
0.73% |
|
Genesco shareholders |